{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:26:10Z","timestamp":1793895970243,"version":"4.8.0"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Commonwealth Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021954","name":"Tour de Cure Ltd","doi-asserted-by":"publisher","award":["RSP-338-2026"],"award-info":[{"award-number":["RSP-338-2026"]}],"id":[{"id":"10.13039\/501100021954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jconrel.2026.115110","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:14:43Z","timestamp":1781651683000},"page":"115110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Turning tumour migration into a therapeutic advantage: Local delivery of chemoattractants for glioblastoma control"],"prefix":"10.1016","volume":"396","author":[{"given":"Samantha J.","family":"Wade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Minaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiarn","family":"Roughley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Aghmesheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy M.","family":"Ainslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara L.","family":"Vine-Perrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jconrel.2026.115110_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140528","article-title":"Recurrent glioblastomas reveal molecular subtypes associated with mechanistic implications of drug-resistance","volume":"10","author":"Kwon","year":"2015","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clineuro.2012.04.005","article-title":"The influence of surgery on recurrence pattern of glioblastoma","volume":"115","author":"De Bonis","year":"2013","journal-title":"Clinical neurology and neurosurgery"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115110_bb0015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"New England journal of medicine"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115110_bb0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"The lancet oncology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12885-025-13757-1","article-title":"The role of temozolomide as adjuvant therapy in glioblastoma management: a systematic review and meta-analysis","volume":"25","author":"Inggas","year":"2025","journal-title":"BMC cancer"},{"issue":"45","key":"10.1016\/j.jconrel.2026.115110_bb0030","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1038\/onc.2016.85","article-title":"A comprehensive profile of recurrent glioblastoma","volume":"35","author":"Campos","year":"2016","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115110_bb0035","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1111\/cas.15773","article-title":"Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma","volume":"114","author":"Wu","year":"2023","journal-title":"Cancer science"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115110_bb0040","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc3078","article-title":"Chemotaxis in cancer","volume":"11","author":"Roussos","year":"2011","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2008.06.017","article-title":"Chemotaxis, chemokine receptors and human disease","volume":"44","author":"Jin","year":"2008","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2176\/nmccrj.2014-0025","article-title":"Double-edged sword in the placement of Carmustine (BCNU) wafers along the eloquent area: a case report","volume":"2","author":"Kuramitsu","year":"2015","journal-title":"NMC case report journal"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115110_bb0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.neurol.2017.09.011","article-title":"How safe are carmustine wafers?","volume":"174","author":"Grangeon","year":"2018","journal-title":"Revue neurologique"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115110_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202200013","article-title":"Localized drug delivery systems in high-grade glioma therapy\u2014from construction to application","volume":"5","author":"Hauck","year":"2022","journal-title":"Advanced Therapeutics"},{"issue":"20","key":"10.1016\/j.jconrel.2026.115110_bb0065","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1080\/17435889.2025.2550239","article-title":"Localized treatment of glioblastoma: a review of clinical strategies and advances in drug delivery systems","volume":"20","author":"Pesce","year":"2025","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0070","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1021\/acsabm.2c00973","article-title":"Drug delivery systems for localized cancer combination therapy","volume":"6","author":"Woodring","year":"2023","journal-title":"ACS applied bio materials"},{"issue":"15","key":"10.1016\/j.jconrel.2026.115110_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202009005","article-title":"Concentration gradients in material sciences: methods to design and biomedical applications","volume":"31","author":"Hua","year":"2021","journal-title":"Advanced Functional Materials"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115110_bb0080","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"International journal of biological sciences"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115110_bb0085","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clinical cancer research"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/cancers13030469","article-title":"The CXCL12 crossroads in cancer stem cells and their niche","volume":"13","author":"L\u00f3pez-Gil","year":"2021","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.jconrel.2026.115110_bb0095","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"The FEBS journal"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115110_bb0100","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3390\/cancers14092291","article-title":"Hypoxia as a modulator of inflammation and immune response in cancer","volume":"14","author":"Castillo-Rodr\u00edguez","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal transduction and targeted therapy"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115110_bb0110","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1007\/s00125-011-2103-y","article-title":"Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells","volume":"54","author":"O\u2019rourke","year":"2011","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115110_bb0115","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.3390\/ijms19103217","article-title":"The role of chemokines in wound healing","volume":"19","author":"Ridiandries","year":"2018","journal-title":"International journal of molecular sciences"},{"key":"10.1016\/j.jconrel.2026.115110_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1084948","article-title":"Immunomodulatory biomaterials on chemokine signaling in wound healing","volume":"14","author":"Apte","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115110_bb0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/path.3029","article-title":"The chemokine system and cancer","volume":"226","author":"Balkwill","year":"2012","journal-title":"The Journal of pathology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/ijms20010096","article-title":"Chemokines and chemokine receptors: orchestrating tumor metastasization","volume":"20","author":"Marcuzzi","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"16","key":"10.1016\/j.jconrel.2026.115110_bb0135","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.3390\/ijms21165647","article-title":"Hypoxia alters the expression of CC chemokines and cc chemokine receptors in a tumor\u2013a literature review","volume":"21","author":"Korbecki","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12195-020-00643-y","article-title":"Stromal cell-derived Factor-1a autocrine\/paracrine signaling contributes to spatiotemporal gradients in the brain","volume":"14","author":"Hickey","year":"2021","journal-title":"Cellular and Molecular Bioengineering"},{"issue":"21","key":"10.1016\/j.jconrel.2026.115110_bb0150","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/jnci\/djm187","article-title":"Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment","volume":"99","author":"Hoelzinger","year":"2007","journal-title":"Journal of the National Cancer Institute"},{"issue":"31","key":"10.1016\/j.jconrel.2026.115110_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201888","article-title":"Perivascular stromal cells instruct glioblastoma invasion, proliferation, and therapeutic response within an engineered brain perivascular niche model","volume":"9","author":"Ngo","year":"2022","journal-title":"Advanced Science"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111511","article-title":"A molecular interactome of the glioblastoma perivascular niche reveals integrin binding sialoprotein as a mediator of tumor cell migration","volume":"41","author":"Ghochani","year":"2022","journal-title":"Cell reports"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccr.2006.11.020","article-title":"A perivascular niche for brain tumor stem cells","volume":"11","author":"Calabrese","year":"2007","journal-title":"Cancer cell"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115110_bb0170","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/ijms22020843","article-title":"The effect of hypoxia on the expression of CXC chemokines and CXC chemokine receptors\u2014a review of literature","volume":"22","author":"Korbecki","year":"2021","journal-title":"International journal of molecular sciences"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0175","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/0008-5472.CAN-03-2073","article-title":"Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population","volume":"64","author":"Brat","year":"2004","journal-title":"Cancer research"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115110_bb0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/cells6040045","article-title":"The role of hypoxia in glioblastoma invasion","volume":"6","author":"Monteiro","year":"2017","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/cas.15587","article-title":"Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastoma","volume":"114","author":"Wei","year":"2023","journal-title":"Cancer Science"},{"key":"10.1016\/j.jconrel.2026.115110_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2023.1227776","article-title":"Impact of simulated brain interstitial fluid flow on the chemokine CXCL12 release from an alginate-based hydrogel in a new 3D in vitro model","volume":"3","author":"El Kheir","year":"2023","journal-title":"Frontiers in Drug Delivery"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-016-2096-y","article-title":"The brain tissue response to surgical injury and its possible contribution to glioma recurrence","volume":"128","author":"Hamard","year":"2016","journal-title":"Journal of neuro-oncology"},{"key":"10.1016\/j.jconrel.2026.115110_bb0200","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fneur.2016.00052","article-title":"Glioma recurrence following surgery: peritumoral or perilesional?","volume":"7","author":"Van der Sanden","year":"2016","journal-title":"Frontiers in Neurology"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115110_bb0205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuron.2013.12.034","article-title":"Reactive gliosis and the multicellular response to CNS damage and disease","volume":"81","author":"Burda","year":"2014","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115110_bb0210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12325-008-0050-x","article-title":"The postoperative brain tumour stem cell (BTSC) niche and cancer recurrence","volume":"25","author":"Liu","year":"2008","journal-title":"Advances in therapy"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115110_bb0215","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/neuonc\/now201","article-title":"Glioma resection and tumor recurrence: back to Semmelweis","volume":"18","author":"Ratel","year":"2016","journal-title":"Neuro-oncology"},{"issue":"27","key":"10.1016\/j.jconrel.2026.115110_bb0220","doi-asserted-by":"crossref","first-page":"11115","DOI":"10.1073\/pnas.1103581108","article-title":"Interstitial flow influences direction of tumor cell migration through competing mechanisms","volume":"108","author":"Polacheck","year":"2011","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"17","key":"10.1016\/j.jconrel.2026.115110_bb0225","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1016\/j.ces.2005.04.008","article-title":"Transient interstitial fluid flow in brain tumors: effect on drug delivery","volume":"60","author":"Teo","year":"2005","journal-title":"Chemical Engineering Science"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s44385-025-00033-x","article-title":"Interstitial fluid transport dynamics predict glioblastoma invasion and progression","volume":"2","author":"Carman-Esparza","year":"2025","journal-title":"NPJ Biomedical Innovations"},{"issue":"13","key":"10.1016\/j.jconrel.2026.115110_bb0235","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1016\/j.cell.2025.03.046","article-title":"Encoding and decoding selectivity and promiscuity in the human chemokine-GPCR interaction network","volume":"188","author":"Kleist","year":"2025","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115110_bb0240","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nri722","article-title":"Chemokine receptors: multifaceted therapeutic targets","volume":"2","author":"Proudfoot","year":"2002","journal-title":"Nature Reviews Immunology"},{"issue":"810","key":"10.1016\/j.jconrel.2026.115110_bb0245","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adf2537","article-title":"Chemokines form complex signals during inflammation and disease that can be decoded by extracellular matrix proteoglycans","volume":"16","author":"Ridley","year":"2023","journal-title":"Science signaling"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115110_bb0250","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.surg.2014.02.006","article-title":"Chemokines and chemokine receptors: update on utility and challenges for the clinician","volume":"155","author":"Roy","year":"2014","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115110_bb0255","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115110_bb0260","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nature Reviews Immunology"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115110_bb0265","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/bjc.2012.49","article-title":"The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer","volume":"106","author":"Popple","year":"2012","journal-title":"British journal of cancer"},{"key":"10.1016\/j.jconrel.2026.115110_bb0270","first-page":"144","article-title":"CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment","volume":"8","author":"W\u00fcrth","year":"2014","journal-title":"Frontiers in cellular neuroscience"},{"issue":"19","key":"10.1016\/j.jconrel.2026.115110_bb0275","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","article-title":"CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells","volume":"76","author":"Chang","year":"2016","journal-title":"Cancer research"},{"key":"10.1016\/j.jconrel.2026.115110_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2016.12.013","article-title":"CCL2\/CCR2 signaling pathway in glioblastoma multiforme","volume":"103","author":"Vakilian","year":"2017","journal-title":"Neurochemistry international"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0285","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","article-title":"The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention","volume":"20","author":"Cambier","year":"2023","journal-title":"Cellular & molecular immunology"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115110_bb0290","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/ph6080929","article-title":"Rationale and means to target pro-inflammatory interleukin-8 (CXCL8) signaling in cancer","volume":"6","author":"Campbell","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2026.115110_bb0295","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","article-title":"The CXCL8-CXCR1\/2 pathways in cancer","volume":"31","author":"Liu","year":"2016","journal-title":"Cytokine & growth factor reviews"},{"key":"10.1016\/j.jconrel.2026.115110_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.723846","article-title":"CXCL8 in tumor biology and its implications for clinical translation","volume":"9","author":"Xiong","year":"2022","journal-title":"Frontiers in molecular biosciences"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115110_bb0305","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3390\/cancers12071765","article-title":"The CCL5\/CCR5 axis in cancer progression","volume":"12","author":"Aldinucci","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115110_bb0310","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.3390\/ijms21124199","article-title":"CCR5-mediated signaling is involved in invasion of glioblastoma cells in its microenvironment","volume":"21","author":"Novak","year":"2020","journal-title":"International journal of molecular sciences"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115110_bb0315","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/cancers12020287","article-title":"Chemokines and their receptors: multifaceted roles in cancer progression and potential value as cancer prognostic markers","volume":"12","author":"Do","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115110_bb0320","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2478\/raon-2019-0057","article-title":"Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme","volume":"53","author":"Kranjc","year":"2019","journal-title":"Radiology and oncology"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115110_bb0325","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/75022","article-title":"Active movement of T cells away from a chemokine","volume":"6","author":"Poznansky","year":"2000","journal-title":"Nature medicine"},{"key":"10.1016\/j.jconrel.2026.115110_bb0330","series-title":"Modeling Brain Extracellular Space From Diffusion Data","author":"Nicholson","year":"2007"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115110_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082382","article-title":"Measurement of biomolecular diffusion in extracellular matrix condensed by fibroblasts using fluorescence correlation spectroscopy","volume":"8","author":"Kihara","year":"2013","journal-title":"PloS one"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033005","article-title":"CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma","volume":"7","author":"Rao","year":"2012","journal-title":"PloS one"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115110_bb0345","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202508142","article-title":"Aggressive glioblastoma cells enhance the migratory persistence and velocity of less aggressive cells to promote tumor dissemination","volume":"22","author":"Mohand","year":"2026","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115110_bb0350","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2184.2002.00246.x","article-title":"A mathematical model of the impact of infused targeted cytotoxic agents on brain tumours: implications for detection, design and delivery","volume":"35","author":"Wein","year":"2002","journal-title":"Cell Proliferation"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115110_bb0355","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The glymphatic system: a beginner\u2019s guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochemical research"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115110_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104987","article-title":"The glymphatic system: current understanding and modeling","volume":"25","author":"Bohr","year":"2022","journal-title":"IScience"},{"key":"10.1016\/j.jconrel.2026.115110_bb0365","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.addr.2021.03.002","article-title":"Harnessing cerebrospinal fluid circulation for drug delivery to brain tissues","volume":"173","author":"Kouzehgarani","year":"2021","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115110_bb0370","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/ijms27020928","article-title":"The glymphatic\u2013immune axis in glioblastoma: mechanistic insights and translational opportunities","volume":"27","author":"Fiallo Arroyo","year":"2026","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115110_bb0375","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/biomedicines14020409","article-title":"Mapping the brain\u2019s glymphatic system","volume":"14","author":"Voumvourakis","year":"2026","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0380","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1754-1611-8-12","article-title":"Effect of tumor shape, size, and tissue transport properties on drug delivery to solid tumors","volume":"8","author":"Sefidgar","year":"2014","journal-title":"Journal of biological engineering"},{"key":"10.1016\/j.jconrel.2026.115110_bb0385","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.msec.2015.10.096","article-title":"Controlled delivery of antibodies from injectable hydrogels","volume":"59","author":"Fletcher","year":"2016","journal-title":"Materials Science and Engineering: C"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115110_bb0390","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nature Reviews Materials"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115110_bb0395","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/pharmaceutics17020215","article-title":"Hydrogels and nanogels: pioneering the future of advanced drug delivery systems","volume":"17","author":"Delgado-Pujol","year":"2025","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115110_bb0400","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.addr.2006.09.004","article-title":"Hydrogels in controlled release formulations: network design and mathematical modeling","volume":"58","author":"Lin","year":"2006","journal-title":"Advanced drug delivery reviews"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115110_bb0405","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.polymer.2008.01.027","article-title":"Hydrogels in drug delivery: progress and challenges","volume":"49","author":"Hoare","year":"2008","journal-title":"Polymer"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0410","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1038\/s41598-023-32257-5","article-title":"Nanocomposite formulation for a sustained release of free drug and drug-loaded responsive nanoparticles: an approach for a local therapy of glioblastoma multiforme","volume":"13","author":"Erthal","year":"2023","journal-title":"Scientific Reports"},{"issue":"23","key":"10.1016\/j.jconrel.2026.115110_bb0415","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1158\/1078-0432.CCR-19-1421","article-title":"Macrophage exclusion after radiation therapy (MERT): a first in human phase I\/II trial using a CXCR4 inhibitor in glioblastoma","volume":"25","author":"Thomas","year":"2019","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115110_bb0420","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/JLB.2BT1018-715RR","article-title":"At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer","volume":"109","author":"Luker","year":"2021","journal-title":"Journal of Leucocyte Biology"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115110_bb0425","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/fon.13.30","article-title":"Translation of the ecological trap concept to glioma therapy: the cancer cell trap concept","volume":"9","author":"van Der Sanden","year":"2013","journal-title":"Future oncology"},{"issue":"19","key":"10.1016\/j.jconrel.2026.115110_bb0430","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1158\/1078-0432.CCR-18-1025","article-title":"Phase I and biomarker study of plerixafor and bevacizumab in recurrent high-grade glioma","volume":"24","author":"Lee","year":"2018","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.jconrel.2026.115110_bb0435","series-title":"A Phase II Study of Plerixafor Combined With Whole Brain Radiation Therapy (WBRT) for Patients With Newly Diagnosed Glioblastoma","author":"Cao","year":"2024"},{"key":"10.1016\/j.jconrel.2026.115110_bb0440","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.actbio.2024.02.007","article-title":"Nanoparticle-mediated blockade of CXCL12\/CXCR4 signaling enhances glioblastoma immunotherapy: monitoring early responses with MRI radiomics","volume":"177","author":"Wei","year":"2024","journal-title":"Acta Biomaterialia"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115110_bb0445","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Phase 1b study targeting tumour associated macrophages with CCR2 inhibition plus FOLFIRINOX in locally advanced and borderline resectable pancreatic cancer","volume":"17","author":"Nywening","year":"2016","journal-title":"The Lancet. Oncology"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0450","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s10637-012-9869-8","article-title":"Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer","volume":"31","author":"Pienta","year":"2013","journal-title":"Investigational new drugs"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0455","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/cas.14306","article-title":"Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer","volume":"111","author":"Masuda","year":"2020","journal-title":"Cancer science"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115110_bb0460","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10549-021-06367-5","article-title":"A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)","volume":"190","author":"Goldstein","year":"2021","journal-title":"Breast cancer research and treatment"},{"key":"10.1016\/j.jconrel.2026.115110_bb0465","series-title":"A Study to Evaluate the Safety and Tolerability of SX-682 in Combination with Nivolumab as a Maintenance Therapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma","author":"Dunne","year":"2026"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115110_bb0470","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2025.12.012","article-title":"Reactive oligodendrocytes promote glioblastoma progression through CCL5\/CCR5-mediated glioma stem cell maintenance","volume":"114","author":"Mikolajewicz","year":"2026","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2026.115110_bb0475","series-title":"Safety, Efficacy, and Clinical Outcomes of the Anti-CCR5 Inhibitor (Leronlimab): A Pooled Analysis of Three Clinical Trials in Patients With mTNBC","author":"Adams","year":"2022"},{"key":"10.1016\/j.jconrel.2026.115110_bb0480","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.annonc.2025.05.146","article-title":"134eP Observed survival following treatment with leronlimab in patients with metastatic colorectal cancer","volume":"36","author":"Baron","year":"2025","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0485","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13058-021-01391-1","article-title":"Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy","volume":"23","author":"Jiao","year":"2021","journal-title":"Breast Cancer Research"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115110_bb0490","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/jpm11080771","article-title":"The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application","volume":"11","author":"Wu","year":"2021","journal-title":"Journal of personalized medicine"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115110_bb0495","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjugate chemistry"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115110_bb0500","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nature reviews materials"},{"key":"10.1016\/j.jconrel.2026.115110_bb0505","series-title":"Frontiers of engineering: Reports on leading-edge engineering from the 2018 symposium","article-title":"Developing targeted theranostic nanoparticles: Challenges and potential solutions","author":"Tsourkas","year":"2019"},{"key":"10.1016\/j.jconrel.2026.115110_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1347877","article-title":"Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features","volume":"15","author":"Ballest\u00edn","year":"2024","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.jconrel.2026.115110_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121205","article-title":"Nanoparticle-containing electrospun nanofibrous scaffolds for sustained release of SDF-1\u03b1","volume":"610","author":"Molina-Pe\u00f1a","year":"2021","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115110_bb0520","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.actbio.2023.10.022","article-title":"Implantable SDF-1\u03b1-loaded silk fibroin hyaluronic acid aerogel sponges as an instructive component of the glioblastoma ecosystem: between chemoattraction and tumor shaping into resection cavities","volume":"173","author":"Molina-Pe\u00f1a","year":"2024","journal-title":"Acta Biomaterialia"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0525","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-02977-x","article-title":"GliaTrap is a biodegradable, non-swelling and non-inflammatory hydrogel with tuned release of CXCL12 to attract migrating glioblastoma cells","volume":"15","author":"Suita","year":"2025","journal-title":"Scientific Reports"},{"issue":"22","key":"10.1016\/j.jconrel.2026.115110_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212150","article-title":"Chemoattraction of neoplastic glial cells with CXCL10, CCL2 and CCL11 as a paradigm for a promising therapeutic approach for primary brain tumors","volume":"22","author":"D\u00e9ry","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.jconrel.2026.115110_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118115","article-title":"An alginate-based macroporous hydrogel matrix to trap cancer cells","volume":"266","author":"Solano","year":"2021","journal-title":"Carbohydrate Polymers"},{"issue":"14","key":"10.1016\/j.jconrel.2026.115110_bb0540","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300671","article-title":"Development of a synthetic, injectable hydrogel to capture residual glioblastoma and glioblastoma stem-like cells with CXCL12-mediated chemotaxis","volume":"12","author":"Khan","year":"2023","journal-title":"Advanced Healthcare Materials"},{"key":"10.1016\/j.jconrel.2026.115110_bb0545","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.actbio.2018.11.027","article-title":"A new glioblastoma cell trap for implantation after surgical resection","volume":"84","author":"Autier","year":"2019","journal-title":"Acta biomaterialia"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0550","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tibtech.2023.09.005","article-title":"Models for evaluating glioblastoma invasion along white matter tracts","volume":"42","author":"Li","year":"2024","journal-title":"Trends in Biotechnology"},{"issue":"21","key":"10.1016\/j.jconrel.2026.115110_bb0555","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1016\/j.biomaterials.2013.03.069","article-title":"Mimicking white matter tract topography using core\u2013shell electrospun nanofibers to examine migration of malignant brain tumors","volume":"34","author":"Rao","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0560","doi-asserted-by":"crossref","DOI":"10.1038\/srep26143","article-title":"Aligned nanotopography promotes a migratory state in glioblastoma multiforme tumor cells","volume":"6","author":"Beliveau","year":"2016","journal-title":"Scientific reports"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115110_bb0565","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.1021\/acsabm.1c00700","article-title":"Cell trapping via migratory inhibition within density-tuned electrospun nanofibers","volume":"4","author":"Huang","year":"2021","journal-title":"ACS Applied Bio Materials"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115110_bb0570","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3390\/cancers15061879","article-title":"The extracellular matrix in glioblastomas: a glance at its structural modifications in shaping the tumoral microenvironment\u2014a systematic review","volume":"15","author":"Marino","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115110_bb0575","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13265","article-title":"Fibrillar extracellular matrix produced by pericyte-like cells facilitates glioma cell dissemination","volume":"34","author":"Vymola","year":"2024","journal-title":"Brain Pathology"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115110_bb0580","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1158\/0008-5472.CAN-08-4859","article-title":"The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells","volume":"69","author":"Ulrich","year":"2009","journal-title":"Cancer research"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115110_bb0585","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/s41563-022-01294-2","article-title":"Negative durotaxis: cell movement toward softer environments","volume":"21","author":"Isomursu","year":"2022","journal-title":"Nature materials"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115110_bb0590","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10555-010-9256-x","article-title":"CXCL12\/CXCR4\/CXCR7 chemokine axis and cancer progression","volume":"29","author":"Sun","year":"2010","journal-title":"Cancer and metastasis reviews"},{"key":"10.1016\/j.jconrel.2026.115110_bb0595","series-title":"CXCR4 and Glioblastoma. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)","first-page":"59","volume":"16","author":"Richardson","year":"2016"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0600","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1005761031077","article-title":"Interstitial fluid flow along white matter tracts: a potentially important mechanism for the dissemination of primary brain tumors","volume":"32","author":"Geer","year":"1997","journal-title":"Journal of Neuro-oncology"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115110_bb0605","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/14728222.2019.1647167","article-title":"Interstitial fluid flow under the microscope: is it a future drug target for high grade brain tumours such as glioblastoma?","volume":"23","author":"Munson","year":"2019","journal-title":"Expert opinion on therapeutic targets"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115110_bb0610","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1158\/0008-5472.CAN-12-2838","article-title":"Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism","volume":"73","author":"Munson","year":"2013","journal-title":"Cancer research"},{"key":"10.1016\/j.jconrel.2026.115110_bb0615","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3389\/fphar.2019.00887","article-title":"Reversing the tumor target: establishment of a tumor trap","volume":"10","author":"Najberg","year":"2019","journal-title":"Frontiers in pharmacology"},{"key":"10.1016\/j.jconrel.2026.115110_bb0620","first-page":"12","article-title":"Stereotactic radiosurgery for glioblastoma","volume":"7","author":"Redmond","year":"2015","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0625","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11060-020-03408-9","article-title":"Convection-enhanced drug delivery for glioblastoma: a review","volume":"151","author":"D\u2019Amico","year":"2021","journal-title":"Journal of Neuro-oncology"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115110_bb0630","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41582-022-00621-0","article-title":"Advances in local therapy for glioblastoma\u2014taking the fight to the tumour","volume":"18","author":"van Solinge","year":"2022","journal-title":"Nature Reviews Neurology"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115110_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2024.102193","article-title":"Rise of implantable drugs: a chronicle of breakthroughs in drug delivery systems","volume":"32","author":"Huanbutta","year":"2024","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0640","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115110_bb0645","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41583-021-00454-8","article-title":"Molecular mechanisms of brain water transport","volume":"22","author":"MacAulay","year":"2021","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.jconrel.2026.115110_bb0650","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.actbio.2018.11.008","article-title":"Biomaterials and glia: Progress on designs to modulate neuroinflammation","volume":"83","author":"Tsui","year":"2019","journal-title":"Acta biomaterialia"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0655","article-title":"Hyaluronan synthesis, catabolism, and signaling in neurodegenerative diseases","volume":"2015","author":"Sherman","year":"2015","journal-title":"International journal of cell biology"},{"issue":"28","key":"10.1016\/j.jconrel.2026.115110_bb0660","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1016\/j.biomaterials.2006.04.045","article-title":"The brain tissue response to biodegradable poly (methylidene malonate 2.1. 2)-based microspheres in the rat","volume":"27","author":"Fournier","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115110_bb0665","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2020.05.041","article-title":"Nanoparticle\u2013hydrogel superstructures for biomedical applications","volume":"324","author":"Jiang","year":"2020","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0670","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-8118-8-7","article-title":"Drug transport in brain via the cerebrospinal fluid","volume":"8","author":"Pardridge","year":"2011","journal-title":"Fluids and Barriers of the CNS"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0675","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41392-025-02177-z","article-title":"Meningeal lymphatic drainage: novel insights into central nervous system disease","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.jconrel.2026.115110_bb0680","doi-asserted-by":"crossref","DOI":"10.1177\/1179069519889027","article-title":"Meningeal lymphatics: a review and future directions from a clinical perspective","volume":"14","author":"Hershenhouse","year":"2019","journal-title":"neuroscience Insights"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115110_bb0685","doi-asserted-by":"crossref","first-page":"100229","DOI":"10.1016\/j.jnrt.2025.100229","article-title":"Decoding the evolution of meningeal lymphatic system research: a decade of bibliometric insights (2015\u2212 2025)","volume":"13","author":"Hou","year":"2025","journal-title":"Journal of Neurorestoratology"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115110_bb0690","doi-asserted-by":"crossref","first-page":"274","DOI":"10.7150\/ijms.22644","article-title":"Risks of using sterilization by gamma radiation: the other side of the coin","volume":"15","author":"Harrell","year":"2018","journal-title":"International journal of medical sciences"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115110_bb0695","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0141-3910(01)00012-X","article-title":"Characterization of degradation on gamma-irradiated recycled polyethylene blends by scanning electron microscopy","volume":"72","author":"Suarez","year":"2001","journal-title":"Polymer degradation and stability"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0700","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.xphs.2018.09.029","article-title":"Impact of ethylene oxide sterilization of polymer-based prefilled syringes on chemical degradation of a model therapeutic protein during storage","volume":"108","author":"Funatsu","year":"2019","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.jconrel.2026.115110_bb0705","doi-asserted-by":"crossref","first-page":"114225","DOI":"10.1016\/j.jconrel.2025.114225","article-title":"Biodegradable nanofibrous scaffolds enhance standard of care for glioblastoma via localized targeted therapy","volume":"387","author":"Woodring","year":"2025","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0710","doi-asserted-by":"crossref","first-page":"8603","DOI":"10.1038\/s41467-025-63692-9","article-title":"Post-resection delivery of a TLR7\/8 agonist from a biodegradable scaffold achieves immune-mediated glioblastoma clearance and protection against tumor challenge in mice","volume":"16","author":"Graham-Gurysh","year":"2025","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0715","doi-asserted-by":"crossref","DOI":"10.1093\/noajnl\/vdag044","article-title":"Tumor resection in glioblastoma mouse models: Surgical techniques and translational potential","volume":"8","author":"Van Nieuwenhuyze","year":"2026","journal-title":"Neuro-oncology advances"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115110_bb0720","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.smim.2007.11.004","article-title":"Foreign body reaction to biomaterials","volume":"20","author":"Anderson","year":"2008","journal-title":"Seminars in immunology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115110_bb0725","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/cn500256e","article-title":"Brain tissue responses to neural implants impact signal sensitivity and intervention strategies","volume":"6","author":"Kozai","year":"2015","journal-title":"ACS chemical neuroscience"},{"issue":"1-2","key":"10.1016\/j.jconrel.2026.115110_bb0730","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2010.05.019","article-title":"Chemokines and glioma: invasion and more","volume":"224","author":"Scium\u00e8","year":"2010","journal-title":"Journal of neuroimmunology"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115110_bb0735","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/neuonc\/noaf118","article-title":"Response assessment in neuro-oncology (RANO) 2009\u20132025: broad scope and implementation\u2014A progress report","volume":"27","author":"Van den Bent","year":"2025","journal-title":"Neuro-oncology"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:47:15Z","timestamp":1793893635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926005134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":147,"alternative-id":["S0168365926005134"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115110","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Turning tumour migration into a therapeutic advantage: Local delivery of chemoattractants for glioblastoma control","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115110"}}